Systemic silencing of Phd2 causes reversible immune regulatory dysfunction
Atsushi Yamamoto(Nuffield Foundation), Christopher W. Pugh(University of Oxford), James McAuliffe(University of Oxford), Kento Kawai(University of Oxford), Benjamin Davies(Centre for Human Genetics), Cheryl L. Scudamore(Mary Lyon Centre at MRC Harwell), Fadi Issa(Oxford Research Group), Hannah Lawson(University of London), Robert Goldin(Imperial College London), Joanna Hester(University of Oxford), Kamil R. Kranc(Institute of Cancer Research), Tanya L. Crockford(University of Oxford), Eleanor Cawthorne(University of Oxford), Elizabeth J. Soilleux(University of Cambridge), Peter J. Ratcliffe(John Radcliffe Hospital), Masateru Uchiyama(University of Oxford), Katherine R. Bull(Centre for Human Genetics), Hiromi Kudo(Imperial College London), Mathew L. Coleman(University of Birmingham), Kate Milward(University of Oxford), Philip S. Macklin(Nuffield Foundation), Daniel Biggs(Centre for Human Genetics), Tammie Bishop(Discovery Institute), Xiaotong Cheng(Nuffield Foundation), Lukas E. Dow(Cornell University)
Cited by 35